# Question

Genenco is developing a new drug that will slow the aging process. In order to succeed, two breakthroughs are needed: one to increase the potency of the drug, and the second to eliminate toxic side effects. Research to improve the drug’s potency is expected to require an upfront investment of $10 million and take 2 years; the drug has a 5% chance of success. Reducing the drug’s toxicity will require a $30 million upfront investment, take 4 years, and has a 20% chance of success. If both efforts are successful, Genenco can sell the patent for the drug to a major drug company for $2 billion. All risk is idiosyncratic, and the risk-free rate is 6%.

a. What is the NPV of launching both research efforts simultaneously?

b. What is the optimal order to stage the investments?

c. What is the NPV with the optimal staging?

a. What is the NPV of launching both research efforts simultaneously?

b. What is the optimal order to stage the investments?

c. What is the NPV with the optimal staging?

## Answer to relevant Questions

Your engineers are developing a new product to launch next year that will require both software and hardware innovations. The software team requests a budget of $5 million and forecasts an 80% chance of success. The hardware ...Suppose venture capital firm GSB partners raised $100 million of committed capital. Each year over the 10-year life of the fund, 2% of this committed capital will be used to pay GSB’s management fee. As is typical in the ...Explain some of the differences between a public debt offering and a private debt offering.Consider a five-year lease for a $400,000 bottling machine, with a residual market value of $150,000 at the end of the five years. If the risk-free interest rate is 6% APR with monthly compounding, compute the monthly lease ...Answer the following questions:a. What is the difference between a firm’s cash cycle and its operating cycle?b. How will a firm’s cash cycle be affected if a firm increases its inventory, all else being equal?c. How will ...Post your question

0